Loading clinical trials...
Loading clinical trials...
A Phase 1/2 Multiple Ascending Dose Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of BMS-911543 in Subjects With Myelofibrosis
Conditions
Interventions
BMS-911543
Locations
5
United States
Mayo Clinic
Rochester, Minnesota, United States
The Mount Sinai School Of Medicine
New York, New York, United States
The University Of Texas Md Anderson Cancer Center
Houston, Texas, United States
Local Institution
East Melbourne, Victoria, Australia
Local Institution
Melbourne, Victoria, Australia
Start Date
April 7, 2011
Primary Completion Date
November 19, 2015
Completion Date
November 19, 2015
Last Updated
July 31, 2019
NCT06980038
NCT07336732
NCT07190248
NCT04704661
NCT07486219
NCT00026884
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions